Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATI-5923 vs Warfarin for Chronic Anticoagulation
NCT00691470Phase 3Unknown
- Sponsor
- ARYx Therapeutics
- Start
- May 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tecarfarin in Atrial fibrillation (AFib), atrial flutter (AFL), venous thromboembolic disease (VTE), myocardial infarction (MI), cardiomyopathy, sponsored by ARYx Therapeutics. Status: unknown.
02
Drugs
tecarfarin
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)venous thromboembolic disease (VTE)myocardial infarction (MI)cardiomyopathy
Beyond the preview
Go deeper on NCT00691470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00691470.